Metronidazol In Viaflo Baxter

Metronidazole, the active ingredient in Metronidazol In Viaflo Baxter, is a nitroimidazole antibiotic presented as an intravenous solution for intravenous use. It treats anaerobic bacterial infections and certain protozoal infections in hospitalized patients.

GNH USA supplies Metronidazol In Viaflo Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Metronidazole is used to treat infections caused by anaerobic bacteria and certain protozoa. - Anaerobic bacterial infections: effective in eradicating susceptible anaerobic organisms in systemic or localized infections. - Trichomoniasis: eliminates the protozoan parasite causing vaginal infection. - Bacterial vaginosis: restores normal vaginal flora by targeting anaerobic bacteria. - Clostridioides difficile infection: reduces toxin‑producing bacteria in the colon. - Intra‑abdominal infections: controls mixed aerobic‑anaerobic infections after surgery or trauma.

Metronidazole may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: persistent metallic sensation in the mouth. - Headache: occasional mild to moderate headache. - Diarrhea: loose stools that may be self‑limiting. - Dizziness: transient light‑headedness. - Abdominal pain: cramping or discomfort.

Serious or Rare Side Effects: - Seizures: rare neurologic events requiring immediate care. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reactions: anaphylaxis, rash, or swelling. - Stevens‑Johnson syndrome: severe skin and mucous membrane reaction. - Neutropenia: low white‑blood‑cell count increasing infection risk. - Hepatic dysfunction: elevated liver enzymes or jaundice.

Metronidazole requires careful monitoring in several clinical situations. - Renal impairment: adjust dosing or monitor plasma levels. - Hepatic dysfunction: use with caution; monitor liver function tests. - Alcohol consumption: avoid due to disulfiram‑like reaction. - Pregnancy: evaluate risk versus benefit; limited data available. - Concurrent warfarin therapy: monitor INR closely for enhanced anticoagulation. - Store at 2‑8°C: keep refrigerated, protect from light, do not freeze.

Metronidazole can interact with other medicines, affecting safety or efficacy.

Major Interactions (Avoid): - Alcohol: may cause severe disulfiram‑like reaction. - Lithium: increased risk of lithium toxicity. - Warfarin: potentiates anticoagulant effect, raising bleeding risk.

Moderate Interactions (Monitor Closely): - Cimetidine: may raise metronidazole plasma concentrations. - Phenobarbital: may reduce metronidazole effectiveness. - Phenytoin: may decrease metronidazole levels and efficacy.